Between 2009 –2014, there were over 2,000 accidental and unintentional opioid involved deaths that
occurred in 150 of Connecticut’s 169 cities and towns.
Naloxone, or Narcan, is the life-saving antidote to an opioid overdose. It is a short acting medication which
revives a persons within a minute or two and allows a window of opportunity to access medical help. Naloxone has
no street value, little to no side effects.
New Milford does offer Naloxone trainings throughout the year. You can also Contact your doctor or pharmacist for a Naloxone kit.
Also,as of 11/2015, AIDS project of Greater Danbury can distribute free Narcan kits with brief training. Contact them (203) 778-2437, 30 West St, Danbury, CT 06810
For more information about Naloxone in CT, please contact:
Shawn M. Lang, Deputy Director of Programs and Policy, AIDS CT
For the AIDS CT Naloxone fact sheet:
Naloxone fact sheet 2015
Current CT Laws related to Narcan:
The 2011 “good Samaritan law” law protects people who call 911 seeking emergency medical services for an overdose from arrest for possession of drugs/paraphernalia.
The 2012 narcan law allows prescribers (physicians, surgeons, Physicians’ Assistants, APRNs, dentists, and podiatrists) to prescribe, dispense or administer narcan to any person to prevent or treat a drug overdose and the prescriber is protected from civil liability and criminal prosecution.
In 2014, protection from civil liability and criminal prosecution was extended to the person administering the narcan in response to an overdose.
The 2015 legislation has several parts including:
Allows pharmacists to prescribe and dispense naloxone (narcan) if they receive special training and certification to do so (in effect now)
Requires physicians, PAs (Physician Assistants), APRNs (Advanced Practice Registered Nurses), and dentists to take continuing education in prescribing controlled substances and pain management (effective October 1, 2015)
Requires prescribers, before prescribing more than a 72 hour supply of a controlled substance, to check the patient’s record in the electronic CT Prescription Monitoring and Reporting System (CPMRS) (effective October 1, 2015)
Requires prescribers, when prescribing controlled substances for prolonged treatment, to review the patient’s record in the CPMRS at least every 90 days (effective October 1, 2015).